General Information of the Compound
Compound ID |
CP0514062
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(2R,3R,4S,5R)-2-[6-[2-(4-aminophenyl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
Show/Hide
|
||||||||||||||||||
Synonyms |
89705-21-5
AKOS030526973
APNEA
Adenosine, N6-2-(4-aminophenyl)ethyl
BDBM50453442
CHEMBL1256714
CS-4923
DTXSID40433272
HMS2233B08
HY-18687
LS-15099
MLS000859964
MLS002153195
N-[2-(4-Aminophenyl)ethyl]-adenosine
N6-2-(4-Aminophenyl)ethyladenosine, >
SCHEMBL1230660
SMR000326823
XTPOZVLRZZIEBW-SCFUHWHPSA-N
ZINC8660412
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C18H22N6O4
|
||||||||||||||||||
Molecular Weight |
386.412
|
||||||||||||||||||
Canonical SMILES |
Nc1ccc(CCNc2ncnc3n(cnc23)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C18H22N6O4/c19-11-3-1-10(2-4-11)5-6-20-16-13-17(22-8-21-16)24(9-23-13)18-15(27)14(26)12(7-25)28-18/h1-4,8-9,12,14-15,18,25-27H,5-7,19H2,(H,20,21,22)/t12-,14-,15-,18-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
XTPOZVLRZZIEBW-SCFUHWHPSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01827, Adenosine receptor A3
Protein ID: PT06109, Geminin
Clinical Information about the Compound